Construction of a broad host range cloning vector conferring triclosan resistance

BioTechniques

Volumn 33, Issue 3, 2002, Pages 490-492

  Kagle, Jeanne ^a   Hay, Anthony G ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; TRICLOSAN; BACTERIAL DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE AMPLIFICATION; GENE EXPRESSION; GENE FUNCTION; GENE ISOLATION; GENE MUTATION; GENE SEQUENCE; HOST RANGE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PROMOTER REGION; CELL LINE; DRUG EFFECT; ESCHERICHIA COLI; EVALUATION; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; METHODOLOGY; MOLECULAR GENETICS; SPECIES DIFFERENCE;

BACTERIA (MICROORGANISMS);

BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC VECTORS; MOLECULAR SEQUENCE DATA; PLASMIDS; SPECIES SPECIFICITY; TRICLOSAN;

EID: 0036753112     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/02333bm05_11845a     Document Type: Article

References (11)

1. Anderson, J.B., C. Sternberg, L.K. Poulsen, S.P. Bjorn, M. Givskov, S. Molin. 1998. New unstable variants of green fluorescent protein for studies of transient gene expression in bacteria. Appl. Environ. Microbiol. 64:2240-2246.
2. Antoine, R. and C. Locht. 1992. Isolation and molecular characterization of a novel broad-host-range plasmid from Bordetella bronchiseptica with sequence similarities to plasmids from Gram-positive organisms. Mol. Microbiol. 6:1785-1799.
3. Bhargava, H.N. and P.A. Leonard. 1996. Triclosan: Applications and safety. Am. J. Infect. Control 24:209-218.
4. Ciba Specialty Chemicals. General Information on Irgasan/Irgacare/Irgacide: Brochure no. 2520. Ciba Specialty Chemicals, Basel, Switzerland.
5. Chuanchuen, R., K. Beinlich, and H.P. Schweizer. 2000. Multidrug efflux pumps and triclosan resistance in Pseudomonas aeruginosa. Abstr. Gen. Meet. Am. Soc. Microbiol. 100:8.
6. Heath, R.J., N. Su, C.K. Murphy, and C.O. Rock. 2000. The enoyl-[acyl carrier protein] reductases, FabI and FabL, from Bacillus subtilis. J. Biol. Chem. 275:40128-40133.
7. Heath, R.J. and C.O. Rock. 2000. A triclosan-resistant bacterial enzyme. Nature 406:145-146.
8. Jones, R.D., H.B. Jampani, J.L. Newman, and A.S. Lee. 2000. Triclosan: A review of effectiveness and safety in health care settings. Am. J. Infect. Control. 28:184-196.
9. Kovach, M.E., P.H. Elzer, D.S. Hill, G.T. Robertson, M.A. Farris, R.M. Roop, II, and K.M. Peterson. 1995. Four new derivatives of the broad-host-range cloning vector pBBRIMCS, carrying different antibiotic-resistance cassettes. Gene 166:175-176.
10. McMurry, L.M., M. Oethinger, and S.B. Levy. 1998. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol. Lett. 166:305-309.
11. McMurry, L.M., M. Oethinger, and S.B. Levy. 1998. Triclosan targets lipid synthesis. Nature 394:531-532.